Author: Dr. Vikram Chauhan

September 12, 2026

Empagliflozin and Ayurvedic Alternatives for Metabolic Disorders

ABSTRACT

Empagliflozin is a selective sodium-glucose cotransporter-2 (SGLT-2) inhibitor developed for the management of metabolic disorders associated with hyperglycemia, insulin resistance, cardiovascular complications, and renal dysfunction. It works by inhibiting glucose reabsorption in the kidneys, thereby increasing urinary glucose excretion and reducing blood glucose levels independently of insulin action. Empagliflozin has gained major clinical importance in the treatment of type 2 diabetes mellitus (T2DM), heart failure, chronic kidney disease (CKD), and metabolic syndrome. Unlike conventional anti-diabetic therapies that mainly improve insulin secretion or sensitivity, Empagliflozin provides additional benefits including weight reduction, cardiovascular protection, blood pressure lowering, and renal preservation. Clinical studies suggest improvements in glycemic control, HbA1c levels, cardiovascular outcomes, renal function, and metabolic parameters, along with a favorable safety profile.

Empagliflozin Metabolic Disorders

INTRODUCTION

Metabolic disorders have become increasingly prevalent worldwide due to sedentary lifestyles, unhealthy dietary habits, obesity, chronic stress, and physical inactivity. Conditions such as type 2 diabetes mellitus (T2DM), obesity, hypertension, cardiovascular disease, chronic kidney disease (CKD), and metabolic syndrome often coexist because of insulin resistance and impaired glucose metabolism. Persistent hyperglycemia significantly increases the risk of cardiovascular disease, kidney dysfunction, neuropathy, and other diabetic complications. Conventional treatment often involves multiple medications for blood sugar control, blood pressure management, and cardiovascular protection, which increases treatment complexity. Empagliflozin was developed as a novel therapeutic agent to improve glycemic control while simultaneously providing cardiovascular and renal benefits. By inhibiting sodium-glucose cotransporter-2 (SGLT-2) in the kidneys, it lowers blood glucose independently of insulin while reducing cardiovascular and renal complications.

WHAT IS EMPAGLIFLOZIN?

Empagliflozin is an oral anti-diabetic drug classified under sodium-glucose cotransporter-2 (SGLT-2) inhibitors. It works by preventing glucose reabsorption in the kidneys, allowing excess sugar to be removed through urine.

The drug was developed to manage metabolic disorders associated with:

  • Type 2 diabetes mellitus (T2DM)
  • Insulin resistance syndrome
  • Metabolic syndrome
  • Heart failure
  • Chronic kidney disease (CKD)
  • Obesity-associated metabolic dysfunction

Empagliflozin has become increasingly important because of its ability to improve blood sugar control while simultaneously protecting the heart and kidneys.

DRUG CLASSIFICATION OF EMPAGLIFLOZIN

Empagliflozin belongs to the following pharmacological categories:

  • Drug Class: Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitor
  • Therapeutic Class: Anti-diabetic agent
  • Pharmacological Action: Selective SGLT-2 inhibitor that increases urinary glucose excretion
  • Route of Administration: Oral tablet

Its unique insulin-independent mechanism distinguishes Empagliflozin from many traditional anti-diabetic medications.

MECHANISM OF ACTION OF EMPAGLIFLOZIN

Empagliflozin acts by selectively inhibiting sodium-glucose cotransporter-2 (SGLT-2), a transporter protein primarily located in the proximal tubules of the kidneys.

SGLT-2 Inhibition

Under normal conditions, kidneys filter glucose and reabsorb nearly all of it back into circulation through SGLT-2 transporters. Empagliflozin blocks this transporter, resulting in:

  • Increased glucose excretion through urine
  • Reduction in blood glucose levels
  • Decreased renal glucose reabsorption
  • Improved glycemic control independent of insulin secretion
  • Cardiovascular and Renal Benefits

Empagliflozin also provides additional metabolic benefits by:

  • Reducing blood pressure through mild diuresis
  • Lowering body weight due to calorie loss through glucose excretion
  • Decreasing cardiovascular mortality risk
  • Protecting kidney function by reducing renal stress and hyperfiltration

These benefits make Empagliflozin particularly valuable in diabetic patients with cardiovascular or renal complications.

PHARMACOKINETICS OF EMPAGLIFLOZIN

Pharmacokinetics refers to how the body absorbs, distributes, metabolizes, and eliminates a drug.

  • Absorption: Empagliflozin is rapidly absorbed after oral administration and reaches peak plasma concentration within a few hours.
  • Distribution: It demonstrates moderate plasma protein binding, ensuring stable therapeutic action.
  • Metabolism: Empagliflozin undergoes limited hepatic metabolism, minimizing significant drug interactions.
  • Elimination: It is eliminated through both urine and feces.
  • Half-Life: The elimination half-life supports once-daily administration, improving patient compliance

INDICATIONS OF EMPAGLIFLOZIN

Type 2 Diabetes Mellitus

Empagliflozin effectively improves glycemic parameters including:

  • Fasting blood sugar
  • Postprandial blood glucose
  • HbA1c levels

It lowers glucose levels independently of insulin action, making it beneficial in insulin resistance.

Heart Failure

Empagliflozin has demonstrated significant benefit in:

  • Reducing hospitalization risk
  • Improving cardiac function
  • Supporting fluid balance and reducing cardiac workload
  • Chronic Kidney Disease (CKD)

Recent studies support its role in:

  • Slowing progression of kidney disease
  • Reducing albuminuria
  • Preserving kidney function
  • Metabolic Syndrome and Obesity

Due to urinary glucose loss and mild calorie depletion, Empagliflozin may support:

  • Weight reduction
  • Blood pressure improvement
  • Better metabolic flexibility

DOSAGE AND ADMINISTRATION

  • Recommended Dosage: 10 mg once daily, which may be increased to 25 mg depending on therapeutic response.
  • Timing: Can be taken with or without meals.
  • Consistency: Take the medication at the same time every day for consistent therapeutic effects.
  • Hydration: Adequate hydration should be maintained due to increased urination.
  • Supervision: Use under physician supervision, especially in patients with kidney disease or cardiovascular conditions.
  • Adjustments: Dose modifications may be required depending on kidney function and associated medical conditions.

SIDE EFFECTS OF EMPAGLIFLOZIN

  • Increased urination
  • Dehydration or excessive thirst
  • Urinary tract infections (UTIs)
  • Genital fungal infections
  • Mild dizziness
  • Less Common but Important Effects
  • Low blood pressure (hypotension)
  • Ketoacidosis (rare but serious)
  • Kidney function disturbances in susceptible individuals
  • Hypoglycemia when combined with insulin or sulfonylureas

Overall, clinical evidence suggests a favorable safety profile when appropriately prescribed and monitored.

LIMITATIONS OF EMPAGLIFLOZIN

Despite its multiple benefits, Empagliflozin has certain limitations:

  • Does not completely reverse lifestyle-related causes of metabolic disorders
  • Increased risk of dehydration in some individuals
  • May not be suitable in severe kidney impairment
  • Requires long-term monitoring in high-risk patients
  • Not a standalone cure for diabetes or metabolic syndrome

AYURVEDIC VIEW OF TYPE 2 DIABETES AND ASSOCIATED METABOLIC DISORDERS

According to Ayurveda, disorders such as diabetes (Prameha), obesity, insulin resistance, and metabolic syndrome develop when digestion (Agni) becomes weak. Due to poor digestion, improperly processed substances accumulate in the body in the form of Ama (toxins). Over time, Ama obstructs the body channels (Srotas), especially those related to fat metabolism, urinary pathways, and nutrient transportation. At the same time, Medo Dhatu (fat tissue) becomes imbalanced, leading to abnormal fat accumulation, obesity, sluggish metabolism, and increased blood sugar levels. Ayurveda explains that Kapha dosha predominates in metabolic disorders, causing heaviness, lethargy, excess body weight, and improper glucose utilization. In chronic conditions such as diabetes, Meda, Mamsa, and Mutravaha Srotas become affected, leading to excessive urination, fatigue, increased thirst, and weakness.

So overall, metabolic disorders in Ayurveda are mainly caused by:

  • Weak digestion (Agnimandya)
  • Accumulation of toxins (Ama)
  • Disturbed fat metabolism (Medo Dhatu Dushti)
  • Increased Kapha dosha
  • Dysfunction of urinary channels (Mutravaha Srotas Dushti)

How Ayurveda manages it

The Ayurvedic treatment approach focuses on correcting the root cause rather than only symptom control:

  • Improving digestion (Deepana & Pachana): Strengthening digestive fire to reduce Ama formation and improve metabolism.
  • Balancing blood sugar (Pramehaghna Chikitsa): Using herbs that support healthy glucose metabolism and insulin sensitivity.
  • Reducing excess fat (Medohara): Supporting proper fat metabolism and reducing obesity-related complications.
  • Detoxification (Shodhana): Removing accumulated toxins and clearing blocked channels.
  • Balancing Kapha: Reducing heaviness, sluggishness, and excessive fluid accumulation.

In simple words, Ayurveda manages metabolic disorders by improving digestion, reducing toxins, supporting glucose metabolism, balancing fat tissue, and restoring metabolic efficiency naturally.

AYURVEDIC ALTERNATIVES TO EMPAGLIFLOZIN

Ayurveda offers a holistic approach using herbs and classical formulations that support glucose metabolism, kidney health, cardiovascular function, and healthy weight management naturally without disturbing physiological balance.

Herbs for Blood Sugar Regulation

  • Gudmar (Gymnema sylvestre): Known as the “sugar destroyer,” it supports healthy blood glucose levels and improves insulin function.
  • Karela (Momordica charantia): Helps maintain healthy glucose metabolism and improves insulin sensitivity.
  • Guduchi (Tinospora cordifolia): Supports metabolism, immunity, and detoxification while helping regulate blood sugar.
  • Methi (Trigonella foenum-graecum): Helps improve insulin sensitivity and reduces glucose spikes after meals.
  • Daruharidra (Berberis aristata): Rich in berberine-like activity, supports glucose metabolism and liver function.

Medohara (Fat-Reducing) Herbs

  • Guggulu (Commiphora mukul): Helps regulate lipid metabolism and reduce excess fat accumulation.
  • Triphala [Emblica officinalis (Amalaki), Terminalia bellerica (Bibhitaki), and Terminalia chebula (Haritaki)]: Improves digestion, detoxification, and supports weight management.
  • Shilajit (Asphaltum punjabinum): Enhances energy metabolism and reduces fatigue often seen in diabetes.
  • Musta (Cyperus rotundus): Supports digestion and improves metabolic balance.

Kidney and Cardiovascular Supportive Herbs

  • Punarnava (Boerhavia diffusa): Supports kidney function, fluid balance, and reduces swelling.
  • Arjuna (Terminalia arjuna): Promotes cardiovascular health and supports healthy circulation.
  • Bhumyamalaki (Phyllanthus niruri): Supports kidney and liver health while reducing inflammation.
  • Gokshura (Tribulus terrestris): Supports urinary health and helps maintain proper kidney function.

CLASSICAL AYURVEDIC FORMULATIONS USED AS BEST ALTERNATIVE FOR EMPAGLIFLOZIN

1. Chandraprabha Vati

Chandraprabha Vati is a classical Ayurvedic formulation widely used in urinary and metabolic disorders, especially Prameha (diabetes). It contains ingredients like Shilajit (Asphaltum punjabianum), Guggulu (Commiphora mukul), Haridra (Curcuma longa), and Musta (Cyperus rotundus), etc., which help improve metabolism and support urinary system function. Since Empagliflozin works by increasing glucose excretion through urine, Chandraprabha Vati may help support healthy urinary function naturally while promoting glucose balance and reducing fatigue.

2. Nishamalaki Churna

Nishamalaki Churna is a traditional combination of Haridra (Curcuma longa) and Amalaki (Emblica officinalis). It is widely used in Ayurveda for blood sugar support. This formulation helps improve glucose metabolism, reduce oxidative stress, and support pancreatic function. It also helps improve digestion and metabolism while reducing complications associated with chronic hyperglycemia.

3. Medohar Guggulu

Medohar Guggulu is beneficial in obesity, metabolic syndrome, and insulin resistance. It contains Guggulu (Commiphora mukul), Musta (Cyperus rotundus), and Vidanga (Embelia ribes), etc., which help reduce excess fat accumulation and improve metabolic activity. It supports healthy body weight and improves sluggish metabolism commonly associated with Kapha dominance.

4. Triphala Guggulu

Triphala Guggulu contains Haritaki (Terminalia chebula), Bibhitaki (Terminalia bellerica), Amalaki (Emblica officinalis), and Shuddh Guggulu (Commiphora mukul). It helps detoxify the body, improve digestion, and support healthy metabolism. It also assists in reducing Ama (Endotoxins) and maintaining tissue health in long-standing metabolic disorders.

ROLE OF LIFESTYLE AND DIET IN METABOLIC DISORDERS: A NATURAL APPROACH SIMILAR TO EMPAGLIFLOZIN ACTION

Lifestyle modification plays an important role in the management of diabetes, obesity, metabolic syndrome, insulin resistance, and cardiovascular risk. Similar to Empagliflozin, which helps improve glucose control and offers heart and kidney protection, healthy lifestyle practices can naturally improve metabolic efficiency and reduce disease progression.

Diet and Nutritional Regulation

A balanced diet rich in fiber, vegetables, whole grains, healthy fats, and low-glycemic foods helps maintain blood sugar levels and supports weight management. Avoiding refined sugar, processed foods, excessive carbohydrates, and fried foods helps improve insulin sensitivity and metabolic health.

Regular Physical Activity

Exercise improves glucose uptake by muscles, supports insulin sensitivity, promotes fat loss, and improves cardiovascular health. Walking, yoga, resistance training, and moderate aerobic exercise are especially beneficial.

Weight Management>

Maintaining a healthy body weight improves insulin resistance, reduces blood sugar fluctuations, and lowers cardiovascular risk. Even moderate weight reduction significantly improves metabolic function.

Hydration and Kidney Support

Proper hydration supports urinary function and kidney health, which is especially important in diabetes management.

Sleep and Stress Management

Poor sleep and chronic stress worsen insulin resistance and hormonal imbalance. Meditation, yoga, pranayama, and proper sleep hygiene help restore metabolic balance.

CONCLUSION

Empagliflozin has emerged as an important therapeutic option in the management of metabolic disorders due to its unique SGLT-2 inhibitory action, which helps improve glycemic control independent of insulin. In addition to lowering blood glucose levels, it offers benefits in weight management, cardiovascular protection, and kidney health, making it valuable in patients with type 2 diabetes mellitus, heart failure, and chronic kidney disease. However, metabolic disorders are complex conditions influenced by poor diet, sedentary lifestyle, obesity, and impaired metabolism, requiring a broader treatment approach. Ayurveda provides a holistic perspective by correcting Agni, reducing Ama, balancing Kapha, and improving Meda Dhatu metabolism through herbs, formulations, lifestyle, and diet. Therefore, an integrative approach combining modern medicine with Ayurvedic principles may provide more effective and sustainable metabolic management.

Continue Reading

September 11, 2026

SAROGLITAZAR AND AYURVEDIC ALTERNATIVES IN THE MANAGEMENT OF METABOLIC DISORDERS

ABSTRACT

Saroglitazar is a novel dual peroxisome proliferator-activated receptor (PPAR) agonist developed for the management of metabolic disorders associated with insulin resistance, dyslipidemia, and chronic inflammation. It primarily acts as a PPAR-alpha agonist with moderate PPAR-gamma activity, helping regulate lipid metabolism and glucose homeostasis simultaneously. Saroglitazar has gained importance in the treatment of diabetic dyslipidemia, hypertriglyceridemia, type 2 diabetes mellitus (T2DM), and non-alcoholic fatty liver disease (NAFLD). Unlike conventional therapies that target a single metabolic pathway, Saroglitazar offers dual benefits by lowering triglyceride levels, improving insulin sensitivity, and supporting glycemic control. Initially approved in India for diabetic dyslipidemia inadequately controlled with statins, it has also shown promising effects in liver-related metabolic disorders. Clinical studies suggest improvements in serum lipids, liver enzymes, inflammatory markers, and glucose metabolism, along with a relatively favorable safety profile.

Saroglitazar Metabolic Disorders

INTRODUCTION

Metabolic disorders have become increasingly common worldwide due to sedentary lifestyles, unhealthy eating habits, obesity, and lack of physical activity. Conditions such as type 2 diabetes mellitus (T2DM), diabetic dyslipidemia, metabolic syndrome, and non-alcoholic fatty liver disease (NAFLD) are major health concerns and often coexist due to a shared underlying factor i.e. insulin resistance. In diabetic patients, abnormal lipid profiles, including high triglycerides, low high-density lipoprotein (HDL), and increased low-density lipoprotein (LDL), significantly raise cardiovascular risk. Conventional management often requires multiple medications to control blood glucose and lipid abnormalities, increasing treatment burden. Saroglitazar was developed as a novel therapeutic agent to address both conditions simultaneously. As a dual PPAR-alpha and PPAR-gamma agonist, it improves lipid metabolism and insulin sensitivity. Additionally, its emerging role in NAFLD and non-alcoholic steatohepatitis (NASH) has expanded its importance in metabolic disease management.

WHAT IS SAROGLITAZAR?

Saroglitazar is an oral anti-diabetic and lipid-modifying drug classified as a dual PPAR agonist. It primarily activates PPAR-alpha receptors and moderately stimulates PPAR-gamma receptors.

The drug was developed to manage metabolic disorders associated with:

  • Diabetic dyslipidemia
  • Hypertriglyceridemia
  • Type 2 diabetes mellitus
  • Insulin resistance syndrome
  • Metabolic syndrome
  • Non-alcoholic fatty liver disease (NAFLD)

Saroglitazar was specifically designed to overcome the limitations of previous glitazar drugs, many of which were withdrawn due to cardiovascular safety concerns and adverse effects.

DRUG CLASSIFICATION OF SAROGLITAZAR

Saroglitazar belongs to the following pharmacological categories:

  • Drug Class: Dual PPAR agonist
  • Therapeutic Class: Anti-diabetic and hypolipidemic agent
  • Pharmacological Action: PPAR-alpha dominant agonist with moderate PPAR-gamma activity
  • Route of Administration: Oral tablet

The dual mechanism of action distinguishes Saroglitazar from standard diabetic medications or isolated lipid-lowering therapies.

MECHANISM OF ACTION OF SAROGLITAZAR

Saroglitazar acts through activation of nuclear receptors called peroxisome proliferator-activated receptors (PPARs). These receptors regulate genes involved in metabolism, inflammation, glucose utilization, and fat storage.

PPAR-Alpha Activatio

Saroglitazar strongly activates PPAR-alpha receptors, mainly present in:

  • Liver
  • Skeletal muscles
  • Heart
  • Kidneys

Activation of PPAR-alpha results in:

  • Enhanced fatty acid oxidation
  • Reduced triglyceride synthesis
  • Increased breakdown of fats
  • Improved lipid clearance from blood
  • Reduction in very low-density lipoproteins (VLDL)

As a result, serum triglyceride levels significantly decrease.

PPAR-Gamma Activation

Saroglitazar moderately activates PPAR-gamma receptors found mainly in adipose tissue, colon and immune cells.

This leads to

  • Improved insulin sensitivity
  • Enhanced glucose uptake by cells
  • Better glycemic control
  • Reduced insulin resistance

The moderate activity minimizes complications such as fluid retention and excessive weight gain often associated with strong PPAR-gamma agonists.

PHARMACOKINETICS OF SAROGLITAZAR

Pharmacokinetics refers to how the body absorbs, distributes, metabolizes, and eliminates a drug.

  • Absorption: Saroglitazar is well absorbed after oral administration and reaches peak plasma concentration within a few hours.
  • Distribution: The drug demonstrates high plasma protein binding, allowing prolonged therapeutic activity.
  • Metabolism: Saroglitazar undergoes limited hepatic metabolism, which reduces the possibility of extensive drug interactions.
  • Elimination: It is primarily excreted through the hepatobiliary route and feces.
  • Half-Life: The elimination half-life supports once-daily dosing, improving patient compliance.

INDICATIONS OF SAROGLITAZAR

  • Diabetic Dyslipidemia: Saroglitazar is especially effective in diabetic patients with high triglyceride levels, low HDL cholesterol, and poor lipid control despite statin therapy, helping improve overall lipid balance and glycemic control.
  • Hypertriglyceridemia: Patients with severe triglyceride elevation benefit significantly from Saroglitazar due to its PPAR-alpha dominant action.

Type 2 Diabetes Mellitus

Saroglitazar improves glycemic parameters including:

  • Fasting blood sugar
  • Postprandial blood glucose
  • HbA1c levels
  • HbA1c levels

Non-Alcoholic Fatty Liver Disease (NAFLD)

Recent evidence supports its role in:

  • Reducing liver fat accumulation
  • Improving liver enzyme levels
  • Decreasing inflammation

Non-Alcoholic Steatohepatitis (NASH): Some studies suggest benefits in preventing fibrosis progression and reducing hepatic inflammation.

DOSAGE AND ADMINISTRATION

Recommended Dosage: 4 mg taken once daily.

Administration Guidelines

Timing: Take the medication before meals.
Consistency: Administer it at the same fixed time every day to maintain consistent levels in your body.
Supervision: Always take this medication under strict physician supervision.

Important Consideration

Adjustments: Your doctor may modify the dose based on your individual response to the treatment and any other associated medical conditions.

SIDE EFFECTS OF SAROGLITAZAR

Although Saroglitazar is generally well tolerated, some patients may experience mild to moderate adverse effects.

Common Side Effects

  • Nausea or gastric discomfort
  • Mild abdominal pain
  • Headache
  • Dizziness
  • Mild weight changes

Less Common but Important Effects

  • Increase in liver enzymes in rare cases
  • Mild edema (fluid retention)
  • Muscle pain or weakness
  • Hypoglycemia (especially when combined with other antidiabetic drugs)

Overall, clinical data suggest a relatively favorable safety profile when used under proper medical supervision.

LIMITATIONS OF SAROGLITAZAR

Despite its dual action, Saroglitazar has certain limitations:

  • Does not reverse underlying lifestyle causes of metabolic disorders
  • Long-term cardiovascular outcome data is still evolving
  • Not a standalone cure for diabetes or NAFLD
  • Requires continuous monitoring of lipid and liver parameters
  • May need combination therapy in advanced metabolic syndrome

AYURVEDIC PERSPECTIVE ON METABOLIC DISORDERS

When the digestive fire (Agni) becomes weak, the body is not able to properly digest food. Because of this, instead of proper nutrients, a sticky toxic substance called Ama is formed. This Ama starts blocking the normal functioning of the body. At the same time, the fat tissue (Medo Dhatu) becomes imbalanced, leading to excess fat accumulation, weight gain, and poor lipid metabolism. This is closely related to modern conditions like obesity, high triglycerides, and fatty liver. Ayurveda also explains that Kapha dosha increases, which makes the body feel heavy, slow, and sluggish. This further slows down metabolism and encourages fat storage.

So overall, metabolic disorders in Ayurveda are mainly caused by:

  • Weak digestion (low Agni)
  • Toxin buildup (Ama)
  • Imbalanced fat tissue (Medo Dhatu Dushti)
  • Increased Kapha (heaviness and sluggishness)

How Ayurveda manages it

The treatment approach is focused on restoring balance:

  • Improving digestion (Deepana & Pachana): Strengthening Agni so food is properly digested
  • Reducing fat (Medohara): Using herbs and therapies that help break down excess fat
  • Detoxification (Shodhana): Removing accumulated toxins from the body when needed
  • Balancing Kapha: Reducing heaviness, improving energy and metabolism

In simple words, Ayurveda treats metabolic disorders by fixing digestion, clearing toxins, balancing fat metabolism, and restoring natural energy flow in the body.

AYURVEDIC ALTERNATIVES TO SAROGLITAZAR

Ayurveda offers a holistic approach using herbs and formulations that support lipid metabolism, glucose control, and liver health without suppressing natural physiological pathways.

Herbs for Lipid and Sugar Regulation

  • Guduchi (Tinospora cordifolia): Improves insulin sensitivity and detoxification
  • Karela (Momordica charantia): Supports natural glucose metabolism
  • Methi (Trigonella foenum-graecum): Helps reduce insulin resistance and triglycerides
  • Daruharidra (Berberis aristata): Supports liver function and fat metabolism

Medohara (Fat-Lowering) Herbs

  • Guggulu (Commiphora mukul): One of the most powerful lipid-regulating herbs
  • Arjuna (Terminalia arjuna): Supports cardiovascular and lipid health
  • Shilajit (Asphaltum punjabinum):Enhances mitochondrial energy metabolism and reduces fat accumulation
  • Triphala [Emblica officinalis (Amalaki), Terminalia bellerica (Bibhitaki), and Terminalia chebula (Haritaki)]: Improves digestion and detoxification

Liver-Supportive Herbs (NAFLD Support)

  • Bhumyamalaki (Phyllanthus niruri): Hepatoprotective and anti-inflammatory
  • Kalmegh (Andrographis paniculata):Reduces liver inflammation and fat deposition
  • Punarnava (Boerhavia diffusa): Helps reduce edema and supports liver-kidney detox

CLASSICAL AYURVEDIC FORMULATIONS USED AS BEST ALTERNATIVE FOR SAROGLITAZAR

Chandraprabha Vati

Chandraprabha Vati is a well-known classical Ayurvedic formulation widely used in metabolic and urinary disorders. It contains a combination of herbs like Shilajit (Asphaltum punjabianum), Guggulu (Commiphora mukul), Haridra (Curcuma longa), and Musta (Cyperus rotundus), etc. which work synergistically to balance metabolism. It is particularly beneficial in metabolic syndrome because it helps regulate glucose metabolism and supports urinary system function. In conditions like diabetes, it helps reduce excessive urination and supports better sugar utilization at the cellular level. It also improves energy levels and reduces fatigue commonly seen in metabolic disorders. Additionally, its action on Meda Dhatu (fat tissue) helps in controlling abnormal fat accumulation.

Arogyavardhini Vati

Arogyavardhini Vati is a powerful classical formulation primarily indicated for liver and skin disorders, but it has strong metabolic benefits as well. It contains ingredients like Shuddh Shilajit (Asphaltum punjabianum), Shuddh Guggulu (Commiphora mukul purified), Chitrak Mool (Plumbago zeylanica), and Kutki (Picrorhiza kurroa), etc. This formulation supports liver detoxification and enhances bile secretion, which plays a key role in lipid metabolism. It helps reduce elevated cholesterol and triglyceride levels by improving hepatic function. In conditions like NAFLD (Non-Alcoholic Fatty Liver Disease), it reduces fat accumulation in liver cells and helps normalize liver enzymes. It also improves digestion and helps in the removal of Ama (toxins), which is essential in metabolic imbalance.

Medohar Guggulu

Medohar Guggulu is specifically formulated for obesity and lipid disorders. Its key ingredient is Guggulu (Commiphora mukul), combined with herbs like Musta (Cyperus rotundus), Vidanga (Embelia ribes), etc. It works mainly by enhancing fat metabolism and reducing excess Meda Dhatu (adipose tissue). The formulation stimulates digestive fire (Agni) and helps break down accumulated fats in the body. It is highly effective in reducing high triglycerides, cholesterol, and body weight when combined with proper diet and lifestyle. It also improves energy metabolism and reduces sluggishness associated with Kapha dominance.

Triphala Guggulu

Triphala Guggulu is a classical combination of Haritaki (Terminalia chebula), Bibhitaki (Terminalia bellerica), Amalaki (Emblica officinalis), Shuddh Guggulu (Commiphora mukul). It is widely used for detoxification and metabolic disorders. This formulation helps in removing deep-seated toxins (Ama) from the body and improves bowel cleansing, which is essential for metabolic balance. It supports fat metabolism and helps reduce excess lipid accumulation in tissues. Triphala provides antioxidant and digestive benefits, while Guggulu enhances fat-burning activity. It is also useful in inflammatory metabolic conditions and helps improve overall tissue health.

ROLE OF LIFESTYLE AND DIET IN METABOLIC DISORDERS: A NATURAL APPROACH SIMILAR TO PPAR ACTIVATION

Lifestyle modification plays a central role in the management of metabolic disorders such as obesity, type 2 diabetes mellitus, dyslipidemia, insulin resistance, and non-alcoholic fatty liver disease (NAFLD). Similar to Saroglitazar, which works by activating Peroxisome Proliferator-Activated Receptors (PPAR-α and PPAR-γ) to improve lipid and glucose metabolism, healthy lifestyle interventions can naturally influence these metabolic pathways and improve overall metabolic health.

Diet and Nutritional Regulation

A balanced diet rich in fiber, healthy fats, antioxidants, and low-glycemic foods helps regulate blood sugar and lipid metabolism. Whole grains, vegetables, nuts, seeds, and omega-3 fatty acids may support PPAR activation, particularly PPAR-α, thereby promoting fatty acid oxidation and reducing triglyceride levels. Restricting processed foods, excess sugar, and trans fats helps improve insulin sensitivity and reduce inflammation.

Regular Physical Activity

Exercise acts as a natural metabolic regulator and is known to enhance PPAR-γ activity, improving glucose uptake and insulin sensitivity in muscles and adipose tissues. Aerobic exercises, brisk walking, and resistance training help lower body fat, improve HDL cholesterol, and reduce triglycerides.

Weight Management

Obesity is closely linked to insulin resistance and metabolic dysfunction. Sustainable weight reduction through calorie balance and physical activity improves metabolic flexibility and reduces fat accumulation in the liver. Weight loss also positively affects PPAR-mediated pathways involved in lipid metabolism.

Sleep and Stress Management

Poor sleep and chronic stress disturb hormonal balance, increase cortisol levels, and worsen insulin resistance. Proper sleep hygiene, meditation, yoga, and stress reduction techniques help maintain metabolic equilibrium and reduce chronic inflammation.

Ayurvedic Lifestyle Perspective

From an Ayurvedic viewpoint, metabolic disorders are associated with Agnimandya (poor digestion), Ama accumulation, and Meda Dhatu Dushti. Following Dinacharya (daily routine), consuming Pathya Ahara (wholesome diet), regular exercise (Vyayama), and avoiding Kapha-aggravating foods help restore metabolic balance naturally.

CONCLUSION

Saroglitazar has emerged as a promising therapeutic agent in the management of metabolic disorders due to its dual PPAR-α and PPAR-γ agonistic action, offering benefits in lipid regulation, glycemic control, insulin sensitivity, and fatty liver management. However, metabolic disorders are multifactorial conditions that also require dietary correction, physical activity, and lifestyle modifications for long-term success. Ayurveda provides a holistic perspective by addressing the root causes through correction of Agni, removal of Ama, balancing Kapha, and improving Meda Dhatu metabolism. Classical formulations such as Chandraprabha Vati, Arogyavardhini Vati, Medohar Guggulu, and Triphala Guggulu may offer supportive metabolic benefits. Therefore, an integrative approach combining modern therapeutics with Ayurvedic principles may provide more comprehensive and sustainable management of metabolic disorders.

Continue Reading

Click the CROSS button to close